101 related articles for article (PubMed ID: 19579600)
21. Microvessel density as new prognostic marker after radiotherapy in rectal cancer.
Svagzdys S; Lesauskaite V; Pavalkis D; Nedzelskiene I; Pranys D; Tamelis A
BMC Cancer; 2009 Mar; 9():95. PubMed ID: 19323831
[TBL] [Abstract][Full Text] [Related]
22. The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer.
Perez RO; São Julião GP; Habr-Gama A; Kiss D; Proscurshim I; Campos FG; Gama-Rodrigues JJ; Cecconello I
Dis Colon Rectum; 2009 Jun; 52(6):1137-43. PubMed ID: 19581858
[TBL] [Abstract][Full Text] [Related]
23. [A case of disease-free survival with low-dose chemotherapy after resection of hepatic and pulmonary metastases from rectal cancer].
Tokunaga Y; Sasaki H; Saito T
Gan To Kagaku Ryoho; 2009 Aug; 36(8):1355-7. PubMed ID: 19692778
[TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor-D is correlated with hepatic metastasis from gastric cancer after radical gastrectomy.
Deng J; Liang H; Sun D; Pan Y; Wang B; Guo Y
Surgery; 2009 Nov; 146(5):896-905. PubMed ID: 19744460
[TBL] [Abstract][Full Text] [Related]
25. Vascular density has prognostic value in Merkel cell carcinoma.
Ng L; Beer TW; Murray K
Am J Dermatopathol; 2008 Oct; 30(5):442-5. PubMed ID: 18806485
[TBL] [Abstract][Full Text] [Related]
26. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.
Kobayashi K; Szklaruk J; Trent JC; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; Hicks ME; Gupta S
Am J Clin Oncol; 2009 Dec; 32(6):574-81. PubMed ID: 19636238
[TBL] [Abstract][Full Text] [Related]
27. The validity of clinical risk score for patients undergoing liver resection for colorectal metastases.
Ivanecz A; Potrc S; Horvat M; Jagric T; Gadzijev E
Hepatogastroenterology; 2009; 56(94-95):1452-8. PubMed ID: 19950809
[TBL] [Abstract][Full Text] [Related]
28. Angiogenic and lymphangiogenic microvessel density in recurrent pleomorphic adenoma.
Soares AB; de Araújo VC; Juliano PB; Altemani A
J Oral Pathol Med; 2009 Sep; 38(8):623-9. PubMed ID: 19563505
[TBL] [Abstract][Full Text] [Related]
29. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis.
Hu H; Sun L; Guo C; Liu Q; Zhou Z; Peng L; Pan J; Yu L; Lou J; Yang Z; Zhao P; Ran Y
Clin Cancer Res; 2009 Sep; 15(17):5485-93. PubMed ID: 19706805
[TBL] [Abstract][Full Text] [Related]
30. Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas.
Liu P; Chen W; Zhu H; Liu B; Song S; Shen W; Wang F; Tucker S; Zhong B; Wang D
Jpn J Clin Oncol; 2009 Oct; 39(10):644-50. PubMed ID: 19648590
[TBL] [Abstract][Full Text] [Related]
31. Locally recurrent rectal cancer in Norway.
Hansen MH; Balteskard L; Dørum LM; Eriksen MT; Vonen B;
Br J Surg; 2009 Oct; 96(10):1176-82. PubMed ID: 19787766
[TBL] [Abstract][Full Text] [Related]
32. The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.
Zubac DP; Bostad L; Kihl B; Seidal T; Wentzel-Larsen T; Haukaas SA
J Urol; 2009 Nov; 182(5):2144-9. PubMed ID: 19758660
[TBL] [Abstract][Full Text] [Related]
33. Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria.
D'Amico F; Schwartz M; Vitale A; Tabrizian P; Roayaie S; Thung S; Guido M; del Rio Martin J; Schiano T; Cillo U
Liver Transpl; 2009 Oct; 15(10):1278-87. PubMed ID: 19790142
[TBL] [Abstract][Full Text] [Related]
34. High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma.
Tamesa T; Iizuka N; Mori N; Okada T; Takemoto N; Tangoku A; Oka M
Hepatogastroenterology; 2009; 56(93):1122-6. PubMed ID: 19760954
[TBL] [Abstract][Full Text] [Related]
35. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
36. Gastric cancer: correlation between clinicopathological factors and survival of patients (III).
Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
Rom J Morphol Embryol; 2009; 50(3):369-79. PubMed ID: 19690762
[TBL] [Abstract][Full Text] [Related]
37. Radiation therapy for lymph node metastases from hepatocellular carcinoma.
Toya R; Murakami R; Yasunaga T; Baba Y; Nishimura R; Morishita S; Nishi J; Beppu T; Baba H; Yamashita Y; Oya N
Hepatogastroenterology; 2009; 56(90):476-80. PubMed ID: 19579624
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
[TBL] [Abstract][Full Text] [Related]
39. [Hepatic metastases of gastrointestinal carcinoma. Clinical and prognostic considerations].
Sisto G; Tarantino S; Lorusso D; Colucci G
Minerva Dietol Gastroenterol; 1987; 33(1):25-8. PubMed ID: 3587689
[No Abstract] [Full Text] [Related]
40. Postoperative recurrence and the role of adjuvant chemotherapy in patients with pulmonary large-cell neuroendocrine carcinoma.
Iyoda A; Hiroshima K; Moriya Y; Iwadate Y; Takiguchi Y; Uno T; Nakatani Y; Yoshino I
J Thorac Cardiovasc Surg; 2009 Aug; 138(2):446-53. PubMed ID: 19619794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
